Annual EBITDA
$1.53B$701.00M-31.46%
Summary
- Current Value
- As of today, SOLV annual EBITDA is $1.53B, down -31.46% on
- Historical Performance
- SOLV annual EBITDA is down -38.33% over the past 3 years, and down -24.74% over the past 5 years
- All-Time High Comparison
- SOLV annual EBITDA is currently -38.33% below its historical high of $2.48B set on
- 3-Year Low Comparison
- SOLV annual EBITDA is at its 3-year low
- Sector Comparison
- SOLV annual EBITDA is higher than 94.91% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.53B | -31.5% | -38.3% | -24.7% | -24.7% | |
| Quarterly EBITDA | $543.00M | +33.1% | -3.9% | -3.9% | -3.9% | |
| TTM EBITDA | $1.81B | -2.2% | +220.2% | +220.2% | +220.2% | |
| Price | $84.24 | +21.4% | – | – | – | |
| PE Ratio | 9.70 | -61.5% | – | – | – | |
| Annual Revenue | $8.25B | +0.7% | +1.0% | +13.4% | +13.4% | |
| Annual EPS | $2.76 | -64.6% | -67.4% | -58.1% | -58.1% | |
| Annual EBIT | $972.00M | -41.7% | -48.3% | -32.0% | -32.0% | |
| Annual Net Income | $479.00M | -64.4% | -67.2% | -57.9% | -57.9% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.27B | N/A | -32.7% |
| 5Y | $2.48B | -38.3% | |
| All | $2.48B | -38.3% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.53B | at low | |
| 5Y | $1.53B | at low | |
| All | $1.53B | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| $1.53B | -31.5% | |
| $2.23B | -1.9% | |
| $2.27B | -8.3% |
| Year | Value | Change |
|---|---|---|
| $2.48B | +22.0% | |
| $2.03B | - |
FAQ
What is the current annual EBITDA of SOLV?
As of today, SOLV annual EBITDA is $1.53B
What is 1-year change in SOLV annual EBITDA?
SOLV annual EBITDA is down -31.46% year-over-year
What is 3-year change in SOLV annual EBITDA?
SOLV annual EBITDA is down -38.33% over the past 3 years
How far is SOLV annual EBITDA from its all-time high?
SOLV annual EBITDA is currently -38.33% below its historical high of $2.48B set on December 1, 2021
How does SOLV annual EBITDA rank versus sector peers?
SOLV annual EBITDA is higher than 94.91% of companies in Healthcare sector
When is SOLV next annual earnings release?
The next annual earnings release for SOLV is on
Quarterly EBITDA
$543.00M$79.00M-12.70%
Summary
- Current Value
- As of today, SOLV quarterly EBITDA is $543.00M, down -12.70% on
- Historical Performance
- SOLV quarterly EBITDA is up +33.09% year-over-year, and down -3.89% over the past 3 years
- All-Time High Comparison
- SOLV quarterly EBITDA is currently -16.20% below its historical high of $648.00M set on
- 3-Year Low Comparison
- SOLV quarterly EBITDA is +73.48% above its 3-year low of $313.00M reached on
- Sector Comparison
- SOLV quarterly EBITDA is higher than 95.48% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $543.00M | -12.7% | +33.1% | -3.9% | -3.9% | |
| Annual EBITDA | $1.53B | – | -31.5% | -38.3% | -24.7% | |
| TTM EBITDA | $1.81B | +8.1% | -2.2% | +220.2% | +220.2% | |
| Price | $84.24 | +16.7% | +21.4% | – | – | |
| PE Ratio | 9.70 | +16.7% | -61.5% | – | – | |
| Quarterly Revenue | $2.10B | -4.0% | +0.7% | +4.3% | +4.3% | |
| Quarterly EPS | $7.22 | +1305.1% | +928.8% | +272.1% | +272.1% | |
| Quarterly EBIT | $429.00M | -14.2% | +56.0% | +1.4% | +1.4% | |
| Quarterly Net Income | $1.27B | +1306.7% | +937.7% | +277.9% | +277.9% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $622.00M | -12.7% | |
| 3Y | $648.00M | -16.2% | |
| 5Y | $648.00M | -16.2% | |
| All | $648.00M | -16.2% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $313.00M | +73.5% | |
| 3Y | $313.00M | +73.5% | |
| 5Y | $313.00M | +73.5% | |
| All | $313.00M | +73.5% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of SOLV?
As of today, SOLV quarterly EBITDA is $543.00M
What is SOLV quarterly EBITDA most recent change?
SOLV quarterly EBITDA was down -12.70% on September 30, 2025
What is 1-year change in SOLV quarterly EBITDA?
SOLV quarterly EBITDA is up +33.09% year-over-year
How far is SOLV quarterly EBITDA from its all-time high?
SOLV quarterly EBITDA is currently -16.20% below its historical high of $648.00M set on September 30, 2023
How does SOLV quarterly EBITDA rank versus sector peers?
SOLV quarterly EBITDA is higher than 95.48% of companies in Healthcare sector
When is SOLV next earnings release?
The next earnings release for SOLV is on
TTM EBITDA
$1.81B$135.00M+8.06%
Summary
- Current Value
- As of today, SOLV TTM EBITDA is $1.81B, up +8.06% on
- Historical Performance
- SOLV TTM EBITDA is down -2.22% year-over-year, and up +220.18% over the past 3 years
- All-Time High Comparison
- SOLV TTM EBITDA is currently -20.06% below its historical high of $2.26B set on
- 3-Year Low Comparison
- SOLV TTM EBITDA is +64.45% above its 3-year low of $1.10B reached on an earlier date
- Sector Comparison
- SOLV TTM EBITDA is higher than 95.21% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.81B | +8.1% | -2.2% | +220.2% | +220.2% | |
| Annual EBITDA | $1.53B | – | -31.5% | -38.3% | -24.7% | |
| Quarterly EBITDA | $543.00M | -12.7% | +33.1% | -3.9% | -3.9% | |
| Price | $84.24 | +16.7% | +21.4% | – | – | |
| PE Ratio | 9.70 | +16.7% | -61.5% | – | – | |
| TTM Revenue | $8.42B | +0.2% | +2.5% | +319.3% | +319.3% | |
| TTM EPS | $8.69 | +300.2% | +108.7% | +347.8% | +347.8% | |
| TTM EBIT | $1.30B | +13.5% | -0.8% | +206.4% | +206.4% | |
| TTM Net Income | $1.52B | +301.9% | +111.5% | +354.6% | +354.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.81B | at high | |
| 3Y | $2.26B | -20.1% | |
| 5Y | $2.26B | -20.1% | |
| All | $2.26B | -20.1% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.43B | +26.6% | |
| 3Y | $1.10B | N/A | +64.5% |
| 5Y | $565.00M | +220.2% | |
| All | $565.00M | +220.2% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of SOLV?
As of today, SOLV TTM EBITDA is $1.81B
What is SOLV TTM EBITDA most recent change?
SOLV TTM EBITDA was up +8.06% on September 30, 2025
What is 1-year change in SOLV TTM EBITDA?
SOLV TTM EBITDA is down -2.22% year-over-year
How far is SOLV TTM EBITDA from its all-time high?
SOLV TTM EBITDA is currently -20.06% below its historical high of $2.26B set on March 31, 2024
How does SOLV TTM EBITDA rank versus sector peers?
SOLV TTM EBITDA is higher than 95.21% of companies in Healthcare sector
When is SOLV next earnings release?
The next earnings release for SOLV is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- SOLV Official Website www.solventum.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1964738/000196473825000091/0001964738-25-000091-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1964738/000196473825000019/0001964738-25-000019-index.htm
- SOLV Profile on Yahoo Finance finance.yahoo.com/quote/SOLV
- SOLV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/solv